Location History:
- Basel, CH (2014)
- Weil am Rhein, DE (2016 - 2018)
Company Filing History:
3 out of 155 
2 out of 60 
Years Active: 2014-2018
Title: Florian Fuchs: Innovator in Wnt Pathway Modulation
Introduction
Florian Fuchs is a notable inventor based in Weil am Rhein, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target the Wnt signaling pathway. With a total of 3 patents to his name, Fuchs is recognized for his innovative approaches to cancer treatment.
Latest Patents
Fuchs' latest patents focus on chromene derivatives and their analogs as Wnt pathway antagonists. These compounds are characterized by specific formulas that include various nitrogen and carbon components. The patents detail their use for modulating Wnt signaling pathway activity and their potential as medicaments, particularly for cancer treatment. The compounds are described as having solvates, hydrates, and pharmaceutically acceptable salts, which enhance their therapeutic applications.
Career Highlights
Throughout his career, Florian Fuchs has worked with prestigious institutions such as the Deutsches Krebsforschungszentrum and Ruprecht-Karls-Universität Heidelberg. His work in these organizations has allowed him to advance his research and contribute to significant scientific discoveries in cancer treatment.
Collaborations
Fuchs has collaborated with notable colleagues, including Daniel Gilbert and Corinna Koch. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking research outcomes.
Conclusion
Florian Fuchs is a prominent figure in the field of medicinal chemistry, with a focus on developing innovative treatments for cancer through the modulation of the Wnt signaling pathway. His contributions and collaborations continue to impact the scientific community positively.